Literature DB >> 15924690

[Novel splice-site mutation in the pre-mRNA splicing gene PRPF31 in a Chinese family with autosomal dominant retinitis pigmentosa].

Sha-Sha Lu1, Chen Zhao, Yun Cui, Ning-Dong Li, Xiu-Mei Zhang, Kan-Xing Zhao.   

Abstract

OBJECTIVE: To identify mutations in a four-generation Chinese family with retinitis pigmentosa and to investigate its clinical phenotype.
METHODS: Ophthalmic and electrophysiological examinations of patients with RP were performed. A genome-wide scan and linkage analysis were conducted in this family. Direct genomic sequencing was used to evaluate the candidate gene. A restriction assay was used to confirm the mutation status in this family, and to exclude it as a polymorphism in a reference population.
RESULTS: The mutation gene was mapped close to RP11 in chromosomal region 19q13.4 by linkage analysis. A novel single heterozygous base substitution (G > C) was detected at the beginning of intron 8 in the PRPF31 gene whereby the consensus GT dinucleotide of the intron 8 splice donor site was changed to CT. The mutation was co-segregated completely with the disease phenotype, but was absent in the unaffected relatives and in 100 reference subjects, thus supporting its pathogenic nature in this family. The clinical findings of RP patients were consistent with a relatively severe and diffuse type of RP.
CONCLUSION: A novel splice site mutation (IVS8 + 1G > C) in the PRPF31 gene caused retinitis pigmentosa in the four-generation Chinese RP family studied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924690

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  6 in total

1.  Dominant retinitis pigmentosa phenotype associated with a new mutation in the splicing factor PRPF31.

Authors:  S Ghazawy; K Springell; V Gauba; M A McKibbin; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

2.  Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay.

Authors:  Thomas Rio Frio; Nicholas M Wade; Adriana Ransijn; Eliot L Berson; Jacques S Beckmann; Carlo Rivolta
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy.

Authors:  Gabrielle Wheway; Andrew Douglas; Diana Baralle; Elsa Guillot
Journal:  Exp Eye Res       Date:  2020-01-31       Impact factor: 3.467

4.  Evaluation of splicing efficiency in lymphoblastoid cell lines from patients with splicing-factor retinitis pigmentosa.

Authors:  Lenka Ivings; Katherine V Towns; M A Matin; Charles Taylor; Frederique Ponchel; Richard J Grainger; Rajkumar S Ramesar; David A Mackey; Chris F Inglehearn
Journal:  Mol Vis       Date:  2008-12-18       Impact factor: 2.367

5.  Novel PRPF31 mutations associated with Chinese autosomal dominant retinitis pigmentosa patients.

Authors:  Fei Xu; Ruifang Sui; Xiaofang Liang; Hui Li; Ruxin Jiang; Fangtian Dong
Journal:  Mol Vis       Date:  2012-12-14       Impact factor: 2.367

6.  A novel PRPF31 mutation in a large Chinese family with autosomal dominant retinitis pigmentosa and macular degeneration.

Authors:  Fang Lu; Lulin Huang; Chuntao Lei; Guiquan Sha; Hong Zheng; Xiaoqi Liu; Jiyun Yang; Yi Shi; Ying Lin; Bo Gong; Xianjun Zhu; Shi Ma; Lifeng Qiao; He Lin; Jing Cheng; Zhenglin Yang
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.